Cargando…
COVID-19: molecular targets, drug repurposing and new avenues for drug discovery
Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious infection that may break the healthcare system of several countries. Here, we aimed at presenting a critical view of ongoing drug repurposing efforts for COVID-19 as...
Autores principales: | Senger, Mario Roberto, Evangelista, Tereza Cristina Santos, Dantas, Rafael Ferreira, Santana, Marcos Vinicius da Silva, Gonçalves, Luiz Carlos Saramago, de Souza Neto, Lauro Ribeiro, Ferreira, Sabrina Baptista, Silva-Junior, Floriano Paes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Oswaldo Cruz, Ministério da Saúde
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534958/ https://www.ncbi.nlm.nih.gov/pubmed/33027420 http://dx.doi.org/10.1590/0074-02760200254 |
Ejemplares similares
-
Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence
por: Moreira-Filho, José T., et al.
Publicado: (2021) -
In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery
por: de Souza Neto, Lauro Ribeiro, et al.
Publicado: (2020) -
Artificial intelligence methods to repurpose and discover new drugs to fight the Coronavirus disease-2019 pandemic
por: Santana, Marcos V.S., et al.
Publicado: (2022) -
The diverse mechanisms and anticancer potential of naphthoquinones
por: Pereyra, Carolina Escardó, et al.
Publicado: (2019) -
Discovery of new Schistosoma mansoni aspartyl protease inhibitors by structure-based virtual screening
por: Gomes, Bárbara Figueira, et al.
Publicado: (2023)